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QUINONES have been shown to be biologically active components by many
workers. They have been reported to act as mitotic poisons on fibroblasts grown
in tissue culture (Meier and Allgower, 1945; Meier and Schar, 1947) and on
embryonic cells of the freshwater annelid Tubifex (Lehmann, 1942, 1945; Huber,
1945, 1947). Mitchell and Simon-Reuss (1947) described the inhibitory effect of
tetrasodium 2-methyl-1: 4-naphthohydroquinone (" Synkavit ") on normal and
malignant cells grown in vitro. Friedmann, Marrian and Simon-Reuss (1948)
have studied the antimitotic activity of 1: 4-naphthohydroquinone diphosphate
and its 2-methyl homologue on cultures of chick fibroblasts in vitro. The former
was found to be 1000 times as active as the latter. Mitchell (1948) also reported
increased radiosensitivity in tumours of patients concurrently treated with
"Synkavit" and has recently (1954) reviewed later researches on this and related
compounds. It was subsequently claimed by Gellhorn and Gagliano (1950)
that "Synkavit" had no appreciable inhibitory effect on the growth of trans-
plantable tumours in mice and rabbits. Quinones have considerable bacterio-
static powers (Hoffmann-Ostenhof, 1947). 9: 10-Phenanthraquinone has a
definite inhibitory effect on tumour growth in mice (Powell, 1951).
The narcotic urethane has been reported by Lasnitzski (1949) and Hughes
(1950) to inhibit mitosis and by Haddow and Sexton (1946) to inhibit tumour
growth in experimental animals. Acenaphthene-quinone, administered parenter-
ally as the water-soluble sodium bisulphite additive compound, has a marked
narcotic effect on experimental animals (Powell, 1949). This possession of
narcotic properties by a quinonoid compound gave reason to investigate its
effects upon tumour growth.
MATERIALS AND MIETHODS.
The transplantable tumours used in this study were Carcinoma 63 in A strain
mice, Sarcoma 37 in R.III and A strain mice, and the following homologous
tumours: a spindle-celled sarcoma and a squamous cell carcinoma in CBA
strain mice (MV8), a polymorphic sarcoma (F2/52) and a squamous cell carcinoma
in R.III strain mice.
Acenaphthenequinone-bisulphite in aqueous solution was administered by
intraperitoneal or subcutaneous injection. Injections were made once daily for
either the duration of an experiment (Experiments 1, 2) or for five consecutive
days (Experiments 3-10) when the mice were concurrently irradiated. The
dosage of the drug was adjusted to the body weight of each mouse. The drug
solution was prepared by saturating 1 per cent sodium metabisulphite in aqueousINHIBITORY EFFECT ON TUMOUR GROWTH
solution with purified acenaphthenequinone. This solution contained approxi-
mately 1.25 per cent acenaphthenequinone-bisulphite and about 0-5 per cent
excess sodium bisulphite which served to stabilise the preparation. The acenaph-
thenequinone-bisulphite content of each preparation was estimated on the basis
of the weight of acenaphthenequinone precipitated by sodium carbonate from an
aliquot of the solution.
All the mice used in each experiment were inoculated subcutaneously with
tissue from the cortex of an actively growing parent tumour. Treatment began
when the transplants were about 24 mm.2 in area. The tumours were measured
twice weekly with calipers and the surface area taken as the product of the major
and minor axes. Inhibition of tumour growth was estimated as the percentage
difference between the increase in area of the tumours of the control and treated
animals from the beginning of treatment. Although this method does not give
an absolute measure of tumour growth, it is adequate for assessing relative
inhibition of growth in comparable experimental conditions.
X-rays were administered by an 88 kV. Siemens Roentgen camera delivering
96 ± 4 r/min. at 3mA. At each irradiation all tumours were treated with half
the total dosage from each of two opposing directions, the centre of a tumour
being placed at the focus of the X-ray beam 10-5 cm. from the aperture. No
filters were used. Lead body shields protected the mice from scattered radiation.
In groups of mice treated with both X-rays and acenaphthenequinone, the
tumours were irradiated approximately 5 minutes after the drug was injected.
The total dose was split into 5 equal doses administered every 24 hours to give a
greater time in which the drug and X-rays might act in combination. In the
experiments described, which are typical in each instance for each set ofconditions,
each group contained 10 mice except Experiments 1 and 2, in which 22 mice
were used in each group.
EXPERIMENTAL RESULTS.
Dosage ofacenaphthenequinone-bisulphite and anaesthetic effect.
The figures given are in terms of mg. acenaphthenequinone-bisulphite in an
approximate 1-25 per cent solution administered by intraperitoneal injection.
For mice of about 25 g. body weight the lethal dosewas found to be 12 i 2 mg.
in R.III and CBA. strain mice, and 10 ± 2 mg. in A strain mice. Mice of the
last strain appear in general to be more susceptible to toxic chemical substances
than mice ofthe former two strains.
The drug had a marked narcotic effect. The duration of anaesthesia varied
considerably with individual mice; for mice of 25 i 3 g. body weight receiving a
dose of 6 mg./20 g. body weight, the duration was 200 i 70 minutes at 8° C.,
110 i 40 minutes at 18° C. and 23 i 3 minutes at 30° C. The minimum
anaesthetic dose was found to be 3'5 0.5 mg. for a mouse of 25 g. body weight.
Deep anaesthesia was induced by dosages of 2 mg. above this level; the muscles
relaxed, respiration was regular, fast and shallow. With sublethal dosages the
skin became cold and irregular gasping occurred.
Effects ofacenaphthenequinone-bisulphite on tumour growth.
The results are listed in Table I. The duration of each experiment is given
from the beg'inning of treatment until the final tumour measurement.
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TABLE I.-Inhibition of Growth of Transplanted Tumours in Mice by Acenaphthene-
quinone-bisulphite and X-irradiation.
Percentage inhibition of
Average tumour growth.
Mg. growth A
drug Duration of of control X-irradia- X-irradia-
Experi- per 20 g. experiment Strain tumours tion tion and Drug
ment. body weight. in days. Tumour. of mice. in mm.2. alone. drug. alone.
1 12
. 11 .Sq.cell. R. III 123 . - - 39
2 7 11 115 -32
3 7 7 90 30 61 48
4
. 4-7
. 8 .,,,,.,, 84 16 52 18
5
. 7
. 7
. S.37
. . 148 . 14 36 42
6
. 5 6
. . A 90 10 38 6
7
. 5
. 8 Sp.cell
. CBA 77 -1 33 -1
8 5
. 11 . MV8
. . 104 . -1 54 3
9 5
. 14
. C.63 A 135
. 7 59
10
. 5
. 14
. F2/52
. R. III 128 2 37
Administration of the drug alone by either the subcutaneous (Experiment 1)
or the intraperitoneal (Experiment 2) route gave tumour growth inhibitions of
39 per cent and 32 per cent, respectively, on the homologous squamous ceJl
carcinoma in R.III strain mice. Larger dosages of the drug could be given by
subcutaneous than intraperitoneal injection; but it was observed that some of
the additive compound hydrolysed to liberate acenaphthenequinone at the site of
injection in the former instance. The inhibitory effect of the drug was found to
be of the same order with both methods of administration. In view of the
difference in drug dosages in these experiments this suggests that the quinone
itselfis not readily absorbed. Acenaphthenequinone is only very slightly soluble
in most aqueous media, and it is probable that injected additive bisulphite
compound is widely dispersed in the animal before hydrolysis is complete.
The combined effect of X-rays and the drug upon the growth of similar
tumours (Experiments 3 and 4) was greater than that given by either agent alone.
Whereas the combined effect of 250 r and 7 mg/20 g. body-weight dosage of drug
was less than the added effects ofthe two agents separately administered (Experi-
ment 3), the converse result was obtained with a lower drug dosage (Experiment
4). A comparable relation was observed in trials of the combined agents upon
Sarcoma 37 (Experiments 5 and 6).
The effect of X-rays and a low drug dosage acting together on homologous
spindle-celled sarcomas (Experiment 7) and squamous cell carcinomas (Experiment
8) in CBA strain mice was found to be disproportionately great in comparison
with the effects of these agents administered singly. Acenaphthenequinone-
bisulphite at a similar dosage also significantly intensified the effect of 250 r on
the growth ofCarcinoma 63 and Sarcoma F2/52 (Experiments 9 and 10). Sodium
bisulphite at concentrations present in the acenaphthenequinone-bisulphite
solutions used was not found to have a significant effect on tumour growth.
DISCUSSION.
From these results it appears that in certain conditions the inhibitory effect
of a combined treatment with X-irradiation and acenaphthenequinone-bisulphite
upon the growth oftransplanted tumours may be significantly greater than would
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be expected ifthe result of the double treatment were a simple summation of the
effects of the two agents acting independently. This augmented combined
effect may not be manifested ifeither the X-irradiation or the drug dosage exceeds
certain limits.
The mechanism of this combined effect on tumour growth is not understood,
although the fact that the irradiation was.carried out while the mice were nar-
cotised by the drug is probably relevant. With a total dosage of 250 r and either
a low or a high dosage of the drug, the combined inhibitory effect was approxi-
mately of the same order (Experiments 3 and 4; 5 and 6).
These results may be explained on the assumption that X-irradiation activates
radicals in the substrate affected by the drug, resulting in more reactive groups
being made available. Alternatively, the acenaphthenequinone-bisulphite might
make tumour cells more sensitive to injury by X-rays. Evidence supporting
this interpretation is that quinones can act as hydrogen-acceptors and mediators
in redox systems; the induced narcosis could affect oxygen concentration in
tumours by diminishing oxygen consumption; and Gray et al. (1954) have shown
that increased oxygen concentration does increase tumour radiosensitivity.
It should be emphasised that in almost all instances the treatment given was
not curative; the inhibition of tumour growth was only partial and treated
tumours tended to recover from the injurious effects after the cessation of treat-
ment. In view of the possible value of methods of radio-sensitisation, the
quantitive relation between drug and X-irradiation dosages and the mechanism
underlying the combined effect of the two agents are being further investigated.
SUMMARY.
1. The effects of acenaphthenequinone-bisulphite, alone and in conjunction
with X-irradiation, upon the growth of various transplantable mouse tumours
have been studied.
2. Acenaphthenequinone-bisulphite had a marked narcotic effect on mice.
3. Acenaphthenequinone-bisulphite administered parenterally significantly
inhibited the growth of transplanted tumours.
4. The inhibition of tumour growth produced by a combined treatment with
250 r X-irradiation, delivered in split dosages of 50 r at daily intervals, and
acenaphthenequinone-bisulphite administered concurrently, was disproportion-
ately greater than the simple summation of the effects of the two agents acting
independently.
5. The induction of the combined inhibitory effect on tumour growth of
X-irradiation and acenaphthenequinone-bisulphite is briefly discussed.
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